Eversept Partners, LP Alector, Inc. Transaction History
Eversept Partners, LP
- $993 Million
- Q2 2025
A detailed history of Eversept Partners, LP transactions in Alector, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 1,986,072 shares of ALEC stock, worth $3.97 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
1,986,072
Previous 617,418
221.67%
Holding current value
$3.97 Million
Previous $759,000
266.27%
% of portfolio
0.28%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding ALEC
# of Institutions
139Shares Held
54.2MCall Options Held
29.8KPut Options Held
13.4K-
Black Rock Inc. New York, NY9.1MShares$18.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$12 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.88MShares$9.75 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.17MShares$4.34 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.98MShares$3.96 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $165M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...